![]() |
![]() |
(+)-Camptothecin (+)-Camptothecine (20S)-CAMPTOTHECIN (4S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (4S)-4-Ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (S)-(+)-Camptothecin (S)-Camptothecin 1,6-DIHYDROXY-7-GLUCURONOSYLFLAVONE 1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)- 1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)- 20(S)-Camptothecin 20(S)-Camptothecine 4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione 4-Ethyl-4-hydroxy-1H-pyrano-[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione 4-ETHYL-4-HYDROXY-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)DIONE 5,6-DIHYDROXY-7-GLUCURONOSYLFLAVONE CaMpathecin CaMpetothecin Camptothecin CaMptothecin(NATURAL) Camptothecin, Camptotheca acuminata Camptothecine d-Camptothecin MAG-CPT NSC 94600 S-CKD 602
2-8℃
Safety Information of Camptothecine (CAS NO.7689-03-4):
Hazard Codes: T,
Xi,
Xn
Risk Statements:36/37/38-25-20/21/22
36/37/38:Irritating to eyes, respiratory system and skin
25:Toxic if swallowed
20/21/22:Harmful by inhalation, in contact with skin and if swallowed
Safety Statements:45-36/37/39-26-36
45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
36/37/39:Wear suitable protective clothing, gloves and eye/face protection
26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36:Wear suitable protective clothing
RIDADR:UN 1544 6.1/PG 3
WGK Germany:3
RTECS Note:UQ0492000
Hazard Note:Irritant
Poison by intravenous and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx. See also CAMPTOTHECIN, SODIUM SALT.
Camptothecine , its cas register number is 7689-03-4. It also can be called (+)-Camptothecin ; 4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione .
1. |
dnd-omi 100 mg/L/30M |
NATUAS Nature. 248 (1974),226. | ||
2. |
dnd-hmn:hla 20 µmol/L |
CNREA8 Cancer Research. 33 (1973),2834. | ||
3. |
dni-hmn:hla 5 µmol/L |
HXPHAU Handbuch der Experimentellen Pharmakologie. 38 (Pt 2),(1975),649. | ||
4. |
oms-hmn:hla 5 µmol/L |
HXPHAU Handbuch der Experimentellen Pharmakologie. 38 (Pt 2),(1975),649. | ||
5. |
oms-mus:lym 1 mg/L |
BCPCA6 Biochemical Pharmacology. 21 (1972),1977. | ||
6. |
dni-ckn:emb 500 µg/L |
CJBIAE Canadian Journal of Biochemistry. 55 (1977),1180. | ||
7. |
ipr-mus LD50:64 mg/kg |
CNREA8 Cancer Research. 39 (1979),2204. | ||
8. |
ivn-mus LD50:38 mg/kg |
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 . |
Acute toxicity - Oral, Category 3
Pictogram(s) | ![]() |
---|---|
Signal word | Danger |
Hazard statement(s) | H301 Toxic if swallowed |
Precautionary statement(s) | |
Prevention | P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. |
Response | P301+P310 IF SWALLOWED: Immediately call a POISON CENTER/doctor/\u2026 P321 Specific treatment (see ... on this label). P330 Rinse mouth. |
Storage | P405 Store locked up. |
Disposal | P501 Dispose of contents/container to ... |
none
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Literatures:
Zhou, Hai-Bin; Liu, Guan-Sai; Yao, Zhu-Jun Organic Letters, 2007 , vol. 9, # 10 p. 2003 - 2005 ![]() Yield: null |